Nigel Russell
15PUBLICATIONS
81CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Jul 03, 2025
Multimodal and Data-Driven Assessment of Myeloid Neoplasms Refines Classification across Disease States.Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard
|Feb 28, 2025
Reply to: Treatment Intensification Based on Residual Disease in Elderly Patients With AML.Nigel H Russell, Abin Thomas, Sylvie D Freeman
|Nov 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial.Nigel H Russell, Abin Thomas, Robert K Hills
|Sep 04, 2024
Risk Stratification in Older Intensively Treated Patients With AML.Jurjen Versluis, Marlen Metzner, Ariel Wang
|Jan 12, 2024
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With <i>NPM1</i> and <i>FLT3</i> Mutations.Nigel H Russell, Charlotte Wilhelm-Benartzi, Jad Othman
|Nov 28, 2023
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial.Mhairi Copland, Cono Ariti, Ian F Thomas
Pageof 3
Frequent Collaborators
5 joint publications
Steven Knapper
5 joint publications
Sylvie Freeman
5 joint publications
Richard Dillon
4 joint publications
Robert K Hills
3 joint publications
Priyanka Mehta
3 joint publications
Amanda Gilkes
3 joint publications
Mary Frances McMullin
3 joint publications
Abin Thomas
3 joint publications
Mike Dennis
2 joint publications
Jad Othman
